TOUYUN BIOTECH (01332): Zhou Ruijuan has been appointed as the company's executive director and vice chairman.
Touyun Biotechnology (01332) announced that Ms. Zhou Ruijuan has been appointed as the company's executive director and vice chairman, responsible for the development of the company's new materials business, effective from August 3, 2026.
TOUYUN BIOTECH (01332) announced that Ms. Zhou Ruijuan has been appointed as the company's Executive Director and Vice Chairman, responsible for the development of the company's new materials business, effective from August 3, 2026.
Related Articles
ALPHAMAB-B(09966): JSKN033 has received approval from CDE to conduct a Phase III clinical study for the treatment of cervical cancer.
Hunan Warrant Pharmaceutical (688799.SH): Ferrous Succinate Tablets and others are expected to be selected for national centralized drug procurement.
US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) surged over 4% after the release of Q&A 3.8-MAX.
ALPHAMAB-B(09966): JSKN033 has received approval from CDE to conduct a Phase III clinical study for the treatment of cervical cancer.
Hunan Warrant Pharmaceutical (688799.SH): Ferrous Succinate Tablets and others are expected to be selected for national centralized drug procurement.
US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) surged over 4% after the release of Q&A 3.8-MAX.
RECOMMEND
